Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 9/1/1988


1.		Phase II Pilot Study of Combination Chemotherapy with 5-FU/THP-Adriamycin/CTX in Patients with Metastatic Breast Cancer (Summary Last Modified 09/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over								MDA-DM-87008 NCI-V88-0433

Last Modified: 5/1/1989


2.		Phase II Combination Chemotherapy with THP-Adriamycin/DTIC in Patients with Metastatic or Unresectable Soft Tissue Sarcomas and Gynecologic Sarcomas (Summary Last Modified 05/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over								MDA-DM-87016 NCI-V88-0434

Last Modified: 11/1/1988


3.		Phase II Study of Pirarubicin (THP) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 11/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				75 or less								EORTC-24873

Last Modified: 2/1/1990


4.		Phase II Study of Pirarubicin in Patients with Unresectable Malignant Mesothelioma (Summary Last Modified 02/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								SCCC-8827 NCI-V89-0309

Last Modified: 10/1/1989


5.		Phase II Study of Pirarubicin in Patients with Metastatic Adenocarcinoma of the Breast (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								PCCC-8725 NCI-V89-0137

Last Modified: 10/1/1989


6.		Phase II Study of Pirarubicin in Patients with Advanced Carcinoma of the Head and Neck (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								PCCC-8726 NCI-V89-0138

Last Modified: 10/1/1989


7.		Phase II Study of Pirarubicin in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 10/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								PCCC-8727 NCI-V89-0139

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute